BBP 2025 is the first ever Bayesian Biostatistics and Pharmaceutical Conference, BBP 2025, organized by the Biostatistics and Pharmaceutical Statistics Section (BioPharm) of the International Society for Bayesian Analysis (ISBA).

The conference will take place in the afternoon of Friday, June 27, 2025 at the University of California Los Angeles (UCLA), USA.

The aim of BBP 2025 is to promote the advancement, application, and dissemination of Bayesian methods in the fields of Biostatistics and Pharmaceutical Statistics.  The conference serves as a platform for researchers and practitioners, within these fields, to strengthen communication and collaboration across academic and industrial communities. 

The scope of the conference encompasses a wide range of topics, including the many facets of biostatistics, as well as the application of statistics to medicine. This includes both clinical and non-clinical aspects of pharmaceutical statistics, such as the optimal design and analysis of clinical trials (drugs, biologics, and medical devices), Bayesian adaptive trial designs, medical decision-making, benefit-risk assessment for regulatory decision-making, model-based drug development (pharmacokinetics, pharmacodynamics, pharmacogenetics), biostatistics, bioinformatics and its applications to genetics, genomics, proteomics, and pharmacoeconomics.

For any further information, please contact Valerie Poynor (vpoynor AT fullerton.edu)